Download PDF
Thromb Haemost 2002; 87(06): 1079-1080
DOI: 10.1055/s-0037-1613138
Letters to the Editor
Schattauer GmbH

Factor V Leiden and Prothrombin Gene Mutations in Femoral Head Osteonecrosis

Charalampos G. Zalavras
1   Department of Orthopaedic Surgery, LAC + USC Medical Center, University of Southern California, Los Angeles, USA
,
George Vartholomatos
2   Haematology Laboratory - Unit of Molecular Biology, University Hospital of Ioannina, Ioannina, Greece
,
Eleni Dokou
2   Haematology Laboratory - Unit of Molecular Biology, University Hospital of Ioannina, Ioannina, Greece
,
Konstantinos N. Malizos
3   Department of Orthopaedic Surgery, University of Thessalia, Larissa, Greece
› Author Affiliations
Further Information

Publication History

Received 30 November 2001

Accepted after resubmission 24 February 2002

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Jones Jr JP. Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. In: Osteonecrosis. Etiology, diagnosis and treatment. Urbaniac JR, Jones Jr JP. eds. Rosemont: American Academy of Orthopaedic Surgeons; 1997: 89-96.
    Google Scholar
  • 2 Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica 1999; 84: 59-70.
    PubMedGoogle Scholar
  • 3 Korompilias A, Ortel T, Gilkeson G, Coogan PG, Gunneson EE, Urbaniak JR. Hypercoagulability and osteonecrosis. In: Osteonecrosis. Etiology, diagnosis and treatment. Urbaniac JR, Jones Jr JP. eds. Rosemont: American Academy of Orthopaedic Surgeons; 1997: 111-6.
    Google Scholar
  • 4 Glueck CJ, Fontaine RN, Gruppo R. et al. The plasminogen activator inhibitor! gene, hypofibrinolysis and osteonecrosis. Clin Orthop 1999; 366: 133-46.
    CrossrefPubMedGoogle Scholar
  • 5 Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 2001; 386: 19-33.
    CrossrefPubMedGoogle Scholar
  • 6 De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V Leiden: clinical implications. Semin Thromb Hemost 1998; 24: 367-79.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Zoller B, Svensson PJ, He X, Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-4.
    CrossrefPubMedGoogle Scholar
  • 8 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’ -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
    PubMedGoogle Scholar
  • 9 Glueck CJ, Freiberg R, Tracy T, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis. Pathophysiologies of osteonecrosis. Clin Orthop 1997; 334: 43-56.
    PubMedGoogle Scholar
  • 10 Zalavras C, Dailiana Z, Elisaf M, Bairaktari E, Vlachogiannopoulos P, Ka-tsaraki A, Malizos KN. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest 2000; 30: 215-21.
    CrossrefPubMedGoogle Scholar
  • 11 de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood 1999; 93: 1271-6.
    PubMedGoogle Scholar
  • 12 Coogan P, Urbaniac JR. Multicenter experience with free vascularized fibular grafts for osteonecrosis of the femoral head. In: Osteonecrosis. Etiology, diagnosis and treatment. Urbaniac JR, Jones Jr JP. eds. Rosemont: American Academy of Orthopaedic Surgeons; 1997: 327-46.
    Google Scholar
  • 13 Soucacos PN, Beris AE, Malizos KN, Korompilias A, Zalavras H, Dailiana Z. Treatment of avascular necrosis of the femoral head with vascularized fibular transplant. Clin Orthop 2001; 386: 120-30.
    CrossrefPubMedGoogle Scholar